A one-year survey of candidemia in Belgium in 2002
Authors:
Open Access
- 1 April 2004
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 132 (6) , 1175-1180
Abstract
A total of 211 episodes of bloodstream yeast infections in 207 patients, hospitalized in 28 Belgian hospitals participating in a National Surveillance Program, were evaluated. A total of 81% of the patients were more than 50 years of age. Candida albicans was the cause of infections in 55% of patients, 22% were due to C. glabrata and 13% to C. parapsilosis. The most common predisposing factors were antibacterial therapy (42%), residence in an intensive care unit (32·9%) and presence of an intravascular catheter (29·7%). Most patients had more than one predisposing factor. Fluconazole alone or in association with another antifungal agent was the treatment of choice for 89·7% of the cases. In vitro susceptibility testing of the isolates revealed that 99% were susceptible to amphotericin B, 95% to 5-fluorocytosine, 82% to fluconazole and 69% to itraconazole. Resistance to azoles was more common among C. glabrata isolates in the elderly. We conclude that the frequency of C. albicans infection is decreasing in Belgium and this is associated with the emergence of other species, most notably, C. glabrata.Keywords
This publication has 17 references indexed in Scilit:
- Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitalsMedical Mycology, 2003
- Hematogenous infections due to Candida parapsilosis: changing trends in fungemic patients at a comprehensive cancer center during the last four decadesDiagnostic Microbiology and Infectious Disease, 2002
- Secular Trend of Hospital‐Acquired Candidemia among Intensive Care Unit Patients in the United States during 1989–1999Clinical Infectious Diseases, 2002
- Yeasts isolated from blood and catheter in children from a Public Hospital of São Paulo, BrazilMycopathologia, 2002
- Aetiology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000Journal of Medical Microbiology, 2002
- The changing spectrum of candidemia in oncology patients: therapeutic implicationsCurrent Opinion in Infectious Diseases, 2000
- The Epidemiology of Candidemia in Two United States Cities: Results of a Population-Based Active SurveillanceClinical Infectious Diseases, 1999
- Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year AnalysisClinical Infectious Diseases, 1999
- Candida parapsilosis Fungemia Associated with Implantable and Semi-Implantable Central Venous Catheters and the Hands of Healthcare WorkersDiagnostic Microbiology and Infectious Disease, 1998
- Candida parapsilosis: Epidemiology, Pathogenicity, Clinical Manifestations, and Antimicrobial SusceptibilityClinical Infectious Diseases, 1992